REQUEST A DEMO
Total
USD $0.00
Search more companies

Nilsan Pharmaceuticals Private Limited (India)

Main Activities: Architectural Services
Full name: Nilsan Pharmaceuticals Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Nilsan Pharmaceuticals Private Limited is an unlisted company, incorporated on 18/07/1996. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U74210DL1996PTC080481 and registration number is 080481. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Unit No B , Basement Floor , Vardhman Grand Plaza , Manglam Palace, Sector 3
North West Delhi; Delhi; Postal Code: 110085

Contact Details: Purchase the Nilsan Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Nilsan Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Nilsan Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
July 18, 1996
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Nilsan Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-12.6%
Total operating revenue
-10.56%
Operating profit (EBIT)
1.73%
EBITDA
2.14%
Net Profit (Loss) for the Period
-5.37%
Total assets
23.65%
Total equity
32.26%
Operating Profit Margin (ROS)
0.36%
Net Profit Margin
0.16%
Return on Equity (ROE)
-9.59%
Debt to Equity Ratio
77.67%
Quick Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?